Updates to the 2024 CSCO advanced non-small cell lung cancer guidelines.

Cancer Biol Med · 2025 · PMC11899588 · PMID 39995197

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

16.7 months, HR = 0.62, P < 0.001) and showed a trend toward OS benefit, with no significant increase in adverse effects 3 .

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.